Champions Oncology Inc (CSBR) Set to Announce Earnings on Thursday
Champions Oncology (OTCMKTS:CSBR) last issued its quarterly earnings data on Thursday, July 27th. The biotechnology company reported ($0.22) EPS for the quarter. Champions Oncology had a negative return on equity of 796.94% and a negative net margin of 65.16%. The company had revenue of $3.72 million during the quarter.
Champions Oncology Inc (OTCMKTS:CSBR) opened at 3.09 on Tuesday. The company’s market capitalization is $33.93 million. Champions Oncology Inc has a one year low of $1.41 and a one year high of $4.79. The firm has a 50-day moving average of $2.97 and a 200 day moving average of $2.84.
ILLEGAL ACTIVITY NOTICE: “Champions Oncology Inc (CSBR) Set to Announce Earnings on Thursday” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://www.thecerbatgem.com/2017/09/05/champions-oncology-inc-csbr-set-to-announce-earnings-on-thursday.html.
Separately, ValuEngine upgraded Champions Oncology from a “sell” rating to a “hold” rating in a report on Friday, June 23rd.
Champions Oncology Company Profile
Champions Oncology, Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans.
Receive News & Stock Ratings for Champions Oncology Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Champions Oncology Inc and related stocks with our FREE daily email newsletter.